Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Changes to assessment of maximum residue limits
An MRL is the highest level of residue from a veterinary medicine that is legally allowed in food for human consumption.
New EMA measures to replace current guidance

Three new regulations to strengthen the assessment of maximum residue limits (MRLs) of veterinary medicines in food-producing animals have been implemented by the European Medicines Agency.

The measures will also serve as key reference documents for companies who apply for the establishment of MRLs for their respective medicine.

An MRL is the highest level of residue from a veterinary medicine that is legally allowed in food for human consumption. Under EU law, food from animals must not contain levels of veterinary medicine that might represent a hazard to the health of the consumer.

The first measure, adopted in January 2017, changes the structure of the documentation to be included in the application dossier for an MRL application by including a new chapter on risk management considerations. It also changes the position in the dossier of the so-called detailed and critical summaries - a summary report provided by experts.  

Measure two, adopted in May 2017, aims to increase the availability of veterinary medicines. It outlines the principles and minimum criteria for the extrapolation of an MRL to either another foodstuff from the same species, or to the same foodstuff from another species.

The third measure, adopted in May 2018, describes the methodology to be used in the scientific risk assessment and establishment of risk management recommendations relevant to MRL applications. The new rules will replace the existing guidance on MRLs in Volume 8 of “The rules governing medicinal products in the European Union" as of 19 June 2018. 

Become a member or log in to add this story to your CPD history

Report: A third of Welsh birds are in decline

News Story 1
 A report by RSPB Cymru and partnering ornithology organisations has revealed that a third of bird species in Wales are in significant decline.

90 per cent of Wales is farmed and there is now pressure to implement new land management policies that will aid in nature restoration.

Patrick Lindley, Maritime Ornithologist for Natural Resources Wales, commented: “The problems that confront UK birds, whether they are breeding or non-breeding, are pressure and threats that confront entire ecosystems.

“Birds are a great indicator to the health of our environment. The continued population declines of birds of farmed, woodland and upland habitats suggest there are large geographic themes that are having a detrimental impact.”  

Click here for more...
News Shorts
BSAVA announces winner of 2019 Bourgelat Award

One of the world’s leading small animal medicine specialists is set to receive the prestigious Bourgelat Award at BSAVA Congress 2019.

Professor Mike Herrtage will be recognised for his major research into metabolic and endocrine diseases, including diabetes mellitus, Cushing’s disease and Addison’s disease.

During his career, Prof Herrtage has co-authored more than 100 scientific papers and written more than 200 other publications such as abstracts, books and chapters. He also continues to be a source of inspiration for thousands of undergraduate and postgraduate veterinary surgeons.